Clinical Trial Update: E10A for the Treatment of Squamous Cell Carcinoma of the Head and Neck [Phase 3]

View source ↗

Summary

This clinical trial update reports a Phase 3 study of E10A for squamous cell carcinoma of the head and neck, sponsored by Guangzhou Double Bioproducts Co., Ltd.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Carcinoma of the Head and Neck

Drugs mentioned

• E10A

Snippet

Sponsor: Guangzhou Double Bioproducts Co., Ltd | Conditions: Head and Neck Neoplasms | Phase 3 | Status: UNKNOWN